OCM
IHE icon

One Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

One Capital Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Hold
13,205
– – 0.03% 287
2026
Q1 		$1.14M Sell
13,205
-2,047
-13% -$179K 0.03% 286
2025
Q4 		$1.29M Sell
15,252
-1,742
-10% -$139K 0.04% 261
2025
Q3 		$1.23M Sell
16,994
-2,872
-14% -$198K 0.04% 239
2025
Q2 		$1.3M Sell
19,866
-3,077
-13% -$200K 0.05% 190
2025
Q1 		$1.62M Sell
22,943
-6,583
-22% -$457K 0.05% 183
2024
Q4 		$1.94M Buy
29,526
+3,777
+15% +$260K 0.06% 162
2024
Q3 		$1.82M Sell
25,749
-1,929
-7% -$134K 0.06% 174
2024
Q2 		$1.84M Buy
27,678
+547
+2% +$35.8K 0.06% 172
2024
Q1 		$1.84M Sell
27,131
-499
-2% -$33K 0.07% 145
2023
Q4 		$1.71M Buy
27,630
+21,210
+330% +$1.25M 0.07% 152
2023
Q3 		$379K Buy
+6,420
New +$394K 0.02% 214

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

One Capital Management's IHE Position: Q2 2026 in Review

One Capital Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 13,205 shares worth $1.14M. The position accounts for 0.03% of the portfolio, ranked #287.

One Capital Management first reported a position in IHE in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.94M in Q4 2024. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • One Capital Management held 13,205 shares of iShares US Pharmaceuticals ETF worth $1.14M as of Q2 2026.
  • One Capital Management left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up 0.03% of One Capital Management's portfolio in Q2 2026, its #287 holding.
  • One Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q3 2023 and has held it in 12 quarters since.
  • One Capital Management's iShares US Pharmaceuticals ETF position peaked at $1.94M in Q4 2024.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.